Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abraxane in advanced NSCLC with EGFR mutations
NCT01620190Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2012
- Primary completion
- Oct 2017
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nab-paclitaxel in non-small cell lung cancer (NSCLC), sponsored by University of Washington. Started Dec 2012; status: completed.
02
Drugs
nab-paclitaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01620190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01620190.